Table 2: The pooled results of Baduanjin exercise for plasma HDL-C level in healthy participants or clinical patients.

ParticipantsNumber of comparisons/T/CMD (95% CI)
(mmol/L)
P value (%)P heterogeneity

Baduanjin + routine treatment versus routine treatment
 Clinical patients 51361360.04 (−0.1, 0.18)73
Baduanjin versus no treatment
 Clinical patients238350.22 (−0.11, 0.55)92
 Healthy participants91401440.13 (0.06, 0.21)56
Baduanjin versus other exercises
 Healthy participants24947−0.09 (−0.25, 0.06)19
Baduanjin + routine versus other exercises + routine treatment
 Clinical patients 31141060.00 (−0.06, 0.07)0

T: The treatment group, C: The control group.